Hepatitis C in Georgia
This PhD project aims to evaluate extrahepatic outcomes of HCV infection, particularly COVID-19- and CVD-related hospitalizations, and adverse perinatal outcomes, in relation to anti-HCV positivity, viremia and treatment statuses on a population level in Georgia.
Specific objectives include:
- To examine the association of HCV infection and treatment statuses with COVID-19-related hospitalization (Paper I).
- To assess the relationship between HCV infection and treatment statuses and CVD-related hospitalizations, specifically for ischemic heart disease, cerebrovascular diseases, and diseases of the arteries, arterioles and capillaries (Paper II).
- To evaluate the association of maternal HCV infection and treatment statuses with preterm birth, low birth weight, and perinatal death (Paper III).
This is the PhD project of Ana Aslanikashvili.
Members:
Erik Eik Anda (Principal investigator) (Project manager)
Tinatin Manjavidze
Charlotta Rylander
Ana Aslanikashvili